The file's text, extracted by GovTribe without its formatting.
Sources Sought Notice
GPO 416801
The Centers for Disease Control and Prevention (CDC) is issuing this sources sought synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for products that will allow the CDC to utilize Illumina testing equipment, MiSeq, MiniSeq, and NextSeq instruments. The use of these instruments and the reagents being purchased allows the CDC to continue to analyze, compare, and compile influenza data with United States public health laboratories and the World Health Organization (WHO) collaborating centers in the WHO Global Influenza Surveillance and Response Network (GISRS) who use the same kits and sequencing platforms and protocols. All data reports from WHO Collaborating Centers in the GISRS are analyzed at the biannual influenza vaccine meetings in Geneva, Switzerland, and are critical for selecting the influenza viruses used in the Northern and Southern Hemisphere annual influenza vaccines. The result of this market research will contribute to determining the method of procurement. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 424210 Diagnostic reagents merchant wholesalers.
There is no solicitation at this time. This request for capability information does not constitute a request for proposals or quotes; submission of any information in response to this market survey is purely voluntary; the government assumes no financial responsibility for any costs incurred.
If your organization has the potential capacity to provide these supplies, please provide the following information: 1) organization name, address, email address, website address, telephone number, and size and type of ownership for the organization; and 2) product information and estimated price for products and delivery scheme as outlined in attachment 1. This does not have to be exact; it is for planning purposes only.
The government will evaluate market information to ascertain potential market availability of the potential of these products being sold by more than one contractor. There are compatibility issues; however, the CDC encourages competition and is seeking a solution, if possible, that could be provided by multiple vendors.
Based on the responses to this sources sought notice/market research, this requirement may be set-aside for small businesses or procured through full and open competition, or procured via a sole source procurement. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions.
Additional Market Research Questions:
1. Does your firm offer the products listed in attachment 1?
2. Can you firm provide the products in the needed timeframes as shown in attachment 1?
3. Are the products offered by your firm made in America or made in other countries? If made outside of the United States, please list the country in which each component is made.
Submission Instructions: Interested parties who consider themselves qualified to provide the above-listed software are invited to submit a response to this Sources Sought Notice by 5:00 PM CDT on July 17, 2024. All responses under this Sources Sought Notice must be emailed to the Contract Specialist, Jennifer Gartzke, at xuy7@cdc.gov. If you have any questions concerning this opportunity, please contact the Contract Specialist.
ATTACHMENT 1
| Part Number |
| Description |
| Quantity |
Shipment 1 – Five Days ARO
| 20060059 |
| ILMN DNA LP (M) Tagmentation (96 Samples, IPB) |
| 14 |
| MS-102-2022 |
| 20 pack - MiSeq Reagent Kit v2 300 cycles |
| 2 |
| 20091654 |
| Illumina DNA/RNA UD Indexes Set A, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091656 |
| Illumina DNA/RNA UD Indexes Set B, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091658 |
| Illumina DNA/RNA UD Indexes Set C, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091660 |
| Illumina DNA/RNA UD Indexes Set D, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20050264 |
| NextSeq 1000/2000 P1 Reagents (300 cycle) |
| 3.5 |
| FC-420-1004 |
| MiniSeq Mid Output Reagent Kit (300 cycle) |
| 4 |
| MS-103-1001 |
| MiSeq Reagent Nano Kit v2(300 cycle) |
| 3 |
| MS-103-1002 |
| MiSeq Reagent Micro Kit v2 (300 cycle) |
| 3 |
Second Shipment – Eight Weeks ARO
| 20060059 |
| ILMN DNA LP (M) Tagmentation (96 Samples, IPB) |
| 14 |
| MS-102-2022 |
| 20 pack - MiSeq Reagent Kit v2 300 cycles |
| 2 |
| 20091654 |
| Illumina DNA/RNA UD Indexes Set A, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091656 |
| Illumina DNA/RNA UD Indexes Set B, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091658 |
| Illumina DNA/RNA UD Indexes Set C, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20091660 |
| Illumina DNA/RNA UD Indexes Set D, Tagmentation (96 Indexes, 96 Samples) |
| 3 |
| 20050264 |
| NextSeq 1000/2000 P1 Reagents (300 cycle) |
| 3.5 |
| FC-420-1004 |
| MiniSeq Mid Output Reagent Kit (300 cycle) |
| 4 |
| MS-103-1001 |
| MiSeq Reagent Nano Kit v2(300 cycle) |
| 3 |
| MS-103-1002 |
| MiSeq Reagent Micro Kit v2 (300 cycle) |
| 3 |
Third Shipment – 16 Weeks ARO
| MS-102-2022 |
| 20 pack - MiSeq Reagent Kit v2 300 cycles |
| 1 |
*ARO – after receipt of order
